Duality Advisers, LP Biomarin Pharmaceutical Inc Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$80.93 - $108.63 $785,668 - $1.05 Million	-9,708 Reduced 43.56%	12,579 $1.3 Million
Q3 2022 Nov 03, 2022	BUY	$82.16 - $96.94 $1.57 Million - $1.86 Million	19,146 Added 609.55%	22,287 $1.89 Million
Q2 2022 Aug 08, 2022	SELL	$71.48 - $86.85 $1.1 Million - $1.33 Million	-15,364 Reduced 83.03%	3,141 $260,000
Q1 2022 May 09, 2022	BUY	$74.28 - $92.69 $1.37 Million - $1.72 Million	18,505 New	18,505 $1.43 Million
Q2 2021 Aug 09, 2021	SELL	$75.51 - $84.79 $2.18 Million - $2.45 Million	-28,895 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $2.16 Million - $2.62 Million	28,895 New	28,895 $2.18 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.